DK1580216T3 - Derivater med høj molekylvægt af camptotheciner - Google Patents
Derivater med høj molekylvægt af camptothecinerInfo
- Publication number
- DK1580216T3 DK1580216T3 DK03769949.3T DK03769949T DK1580216T3 DK 1580216 T3 DK1580216 T3 DK 1580216T3 DK 03769949 T DK03769949 T DK 03769949T DK 1580216 T3 DK1580216 T3 DK 1580216T3
- Authority
- DK
- Denmark
- Prior art keywords
- camptothecins
- molecular weight
- high molecular
- weight derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polyamides (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002316942 | 2002-10-31 | ||
| PCT/JP2003/013838 WO2004039869A1 (ja) | 2002-10-31 | 2003-10-29 | カンプトテシン類の高分子誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1580216T3 true DK1580216T3 (da) | 2014-08-18 |
Family
ID=32211705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03769949.3T DK1580216T3 (da) | 2002-10-31 | 2003-10-29 | Derivater med høj molekylvægt af camptotheciner |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7495099B2 (da) |
| EP (1) | EP1580216B1 (da) |
| JP (1) | JP4745664B2 (da) |
| KR (1) | KR101057102B1 (da) |
| CN (1) | CN1309763C (da) |
| AU (1) | AU2003280592B2 (da) |
| CA (1) | CA2502870C (da) |
| DK (1) | DK1580216T3 (da) |
| ES (1) | ES2488841T3 (da) |
| PT (1) | PT1580216E (da) |
| RU (1) | RU2315782C2 (da) |
| TW (1) | TW200418906A (da) |
| WO (1) | WO2004039869A1 (da) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100475269C (zh) * | 2002-03-05 | 2009-04-08 | 北京键凯科技有限公司 | 亲水性聚合物-谷氨酸寡肽与药物分子的结合物、包含该结合物的组合物及用途 |
| AU2003221291A1 (en) | 2002-03-13 | 2003-09-22 | Beijing Jiankai Technology Co., Ltd. | Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
| CN102516417B (zh) | 2002-09-06 | 2014-12-10 | 天蓝制药公司 | 用于传递治疗剂的以环糊精为基础的聚合物 |
| KR101203475B1 (ko) * | 2004-09-22 | 2012-11-21 | 니폰 가야꾸 가부시끼가이샤 | 신규 블록 공중합체, 미셀 제제물 및 이를 유효성분으로함유하는 항암제 |
| ATE432955T1 (de) | 2005-12-05 | 2009-06-15 | Nitto Denko Corp | Polyglutamat-aminosäure-konjugate und verfahren |
| KR20080106254A (ko) | 2006-03-28 | 2008-12-04 | 니폰 가야꾸 가부시끼가이샤 | 탁산류의 고분자 결합체 |
| US8940332B2 (en) | 2006-05-18 | 2015-01-27 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of podophyllotoxins |
| RU2009105670A (ru) | 2006-07-19 | 2010-08-27 | Ниппон Каяку Кабусики Кайся (Jp) | Высокомолекулярный конъюгат комбретастатинов |
| JP5548364B2 (ja) * | 2006-10-03 | 2014-07-16 | 日本化薬株式会社 | レゾルシノール誘導体の高分子結合体 |
| EP2080779B1 (en) | 2006-11-06 | 2016-05-18 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
| JP5548365B2 (ja) | 2006-11-08 | 2014-07-16 | 日本化薬株式会社 | 核酸系代謝拮抗剤の高分子誘導体 |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
| ES2430380T3 (es) | 2007-05-09 | 2013-11-20 | Nitto Denko Corporation | Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido |
| JP5349318B2 (ja) * | 2007-09-28 | 2013-11-20 | 日本化薬株式会社 | ステロイド類の高分子結合体 |
| CA2716662A1 (en) * | 2008-03-06 | 2009-03-11 | Nitto Denko Corporation | Polymer paclitaxel conjugates and methods for treating cancer |
| EP2258397B1 (en) * | 2008-03-18 | 2017-10-11 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of physiologically active substance |
| WO2009136572A1 (ja) | 2008-05-08 | 2009-11-12 | 日本化薬株式会社 | 葉酸若しくは葉酸誘導体の高分子結合体 |
| ES2396134T3 (es) | 2008-05-23 | 2013-02-19 | Nanocarrier Co., Ltd. | Derivado polimérico de docetaxel, método de preparación del mismo y sus usos |
| JP2011162569A (ja) | 2008-05-23 | 2011-08-25 | Nano Career Kk | カンプトテシン高分子誘導体及びその用途 |
| US20110293515A1 (en) * | 2009-01-13 | 2011-12-01 | The Uab Research Foundation | Heterofunctional segment-poly (ethylene glycol) polymers as delivery vehicles |
| JP2012526049A (ja) * | 2009-05-04 | 2012-10-25 | インテザイン テクノロジーズ， インコーポレイテッド | 腫瘍治療のためのｓｎ−３８を含有するポリマーミセル |
| CN102421827B (zh) | 2009-05-15 | 2014-07-30 | 日本化药株式会社 | 具有羟基的生理活性物质的高分子结合体 |
| US20120231053A1 (en) * | 2009-10-21 | 2012-09-13 | Nippon Kayaku Kabushiki Kaisha | Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient |
| JP2011225510A (ja) * | 2010-04-01 | 2011-11-10 | National Cancer Center | 新規な抗腫瘍剤 |
| EP2641605B1 (en) | 2010-11-17 | 2018-03-07 | Nippon Kayaku Kabushiki Kaisha | Polymer derivative of cytidine metabolism antagonist |
| EP2754682B1 (en) | 2011-09-11 | 2017-06-07 | Nippon Kayaku Kabushiki Kaisha | Method for manufacturing block copolymer |
| WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| JP6223995B2 (ja) * | 2012-11-08 | 2017-11-01 | 日本化薬株式会社 | カンプトテシン類と抗癌効果増強剤の結合した高分子化合物及びその用途 |
| AU2014331591B2 (en) | 2013-10-04 | 2018-08-16 | Prolynx Llc | Slow-release conjugates of SN-38 |
| JP6580030B2 (ja) * | 2014-02-19 | 2019-09-25 | 日本化薬株式会社 | カンプトテシン誘導体とｈｓｐ９０阻害剤の結合した高分子化合物及びその用途 |
| WO2015125641A1 (ja) * | 2014-02-19 | 2015-08-27 | 日本化薬株式会社 | 高分子化カンプトテシン誘導体及び高分子化ｈｓｐ９０阻害剤誘導体を含む医薬組成物 |
| JP2016124818A (ja) * | 2014-12-26 | 2016-07-11 | 日本化薬株式会社 | 転移性肝癌治療薬及び転移性肝癌の治療方法 |
| WO2016103867A1 (ja) * | 2014-12-26 | 2016-06-30 | 日本化薬株式会社 | カンプトテシン類高分子誘導体の医薬製剤 |
| RU2732612C2 (ru) * | 2015-02-23 | 2020-09-21 | Ниппон Каяку Кабусики Каися | Блок-сополимерный конъюгат физиологически активного вещества |
| EP3315487B1 (en) | 2015-06-24 | 2020-10-28 | Nippon Kayaku Kabushiki Kaisha | Novel platinum (iv) complex |
| JP6735759B2 (ja) * | 2015-09-03 | 2020-08-05 | 日本化薬株式会社 | カンプトテシン類高分子誘導体を含有する医薬組成物 |
| WO2017047497A1 (ja) | 2015-09-14 | 2017-03-23 | 日本化薬株式会社 | ６配位白金錯体の高分子結合体 |
| WO2017100533A1 (en) * | 2015-12-09 | 2017-06-15 | Board Of Regents, The University Of Texas System | Polymeric drug delivery systems for treatment of disease |
| US11433136B2 (en) | 2015-12-18 | 2022-09-06 | The General Hospital Corporation | Polyacetal polymers, conjugates, particles and uses thereof |
| AU2016374759B2 (en) | 2015-12-22 | 2021-04-01 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of sulfoxide derivative-coordinated platinum(II) complex |
| WO2017150256A1 (ja) | 2016-03-01 | 2017-09-08 | 日本化薬株式会社 | カンプトテシン類高分子誘導体を含有する医薬製剤 |
| CN109476841B (zh) | 2016-07-30 | 2021-08-24 | 日本化药株式会社 | 新型高分子衍生物和使用其的新型高分子衍生物成像探针 |
| CN109642024A (zh) | 2016-08-02 | 2019-04-16 | 日本化药株式会社 | 主动靶向型高分子衍生物、包含该高分子衍生物的组合物以及它们的用途 |
| CN106496542B (zh) * | 2016-09-23 | 2018-06-22 | 天津科技大学 | 谷胱甘肽敏感的两亲性聚乙二醇-羟基喜树碱偶联物 |
| WO2018106738A1 (en) | 2016-12-05 | 2018-06-14 | Massachusetts Institute Of Technology | Brush-arm star polymers, conjugates and particles, and uses thereof |
| KR20200027518A (ko) | 2017-06-30 | 2020-03-12 | 메사추세츠 인스티튜트 오브 테크놀로지 | 분지형 다관능성 거대단량체 및 관련 중합체 및 그의 용도 |
| JP2021510701A (ja) | 2018-01-12 | 2021-04-30 | プロリンクス エルエルシー | 併用投与の毒性を最小化するためのプロトコルおよび検証用のイメージング剤 |
| US10988491B2 (en) | 2018-08-17 | 2021-04-27 | Massachusetts Institute Of Technology | Degradable polymers of a cyclic silyl ether and uses thereof |
| WO2020236253A1 (en) | 2019-05-20 | 2020-11-26 | Massachusetts Institute Of Technology | Boronic ester prodrugs and uses thereof |
| WO2021141662A1 (en) | 2020-01-10 | 2021-07-15 | Massachusetts Institute Of Technology | Proteolysis targeting chimeric molecules (protacs) with functional handles and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5839683A (ja) * | 1981-09-04 | 1983-03-08 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
| JPS6247193A (ja) | 1985-08-26 | 1987-02-28 | 内橋エステック株式会社 | 電子部品のはんだ付方法 |
| JP2517760B2 (ja) * | 1989-05-11 | 1996-07-24 | 新技術事業団 | 水溶性高分子化医薬製剤 |
| JP3310000B2 (ja) | 1990-11-07 | 2002-07-29 | 靖久 桜井 | 水溶性高分子抗癌剤及び薬物担持用担体 |
| JPH05117385A (ja) * | 1991-10-31 | 1993-05-14 | Res Dev Corp Of Japan | ブロツク共重合体の製造法、ブロツク共重合体及び水溶性高分子抗癌剤 |
| JP3270592B2 (ja) * | 1992-10-26 | 2002-04-02 | 日本化薬株式会社 | ブロック共重合体−抗癌剤複合体医薬製剤 |
| JP3268913B2 (ja) | 1992-10-27 | 2002-03-25 | 日本化薬株式会社 | 高分子担体 |
| US5840900A (en) | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| JP2694923B2 (ja) | 1995-08-21 | 1997-12-24 | 科学技術振興事業団 | 水溶性高分子化医薬製剤 |
| US6153655A (en) | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| US6207832B1 (en) | 1999-04-09 | 2001-03-27 | University Of Pittsburgh | Camptothecin analogs and methods of preparation thereof |
| IL151685A0 (en) * | 2000-03-17 | 2003-04-10 | Cell Therapeutics Inc | Polyglutamic acid-camptothecin conjugates, methods for the preparation thereof and pharmaceutical compositons containing the same |
| CA2410526C (en) * | 2000-06-02 | 2012-04-17 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| DE60235812D1 (de) * | 2001-06-20 | 2010-05-12 | Nippon Kayaku Kk | Blockcopolymer mit verringertem verunreinigungsgehalt, polymerer träger, pharmazeutische zubereitungen in polymerer form und verfahren zur herstellung davon |
| JP2003342167A (ja) * | 2002-05-24 | 2003-12-03 | Nano Career Kk | カンプトテシン誘導体の製剤およびその調製方法 |
| JP2003342168A (ja) | 2002-05-24 | 2003-12-03 | Nano Career Kk | 注射用薬物含有ポリマーミセル製剤の製造方法 |
| WO2004084871A1 (en) * | 2003-03-26 | 2004-10-07 | Ltt Bio-Pharma Co., Ltd. | Intravenous nanoparticles for targenting drug delivery and sustained drug release |
| EP1881020B1 (en) * | 2005-05-11 | 2010-08-11 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of cytidine metabolic antagonist |
-
2003
- 2003-10-29 US US10/532,670 patent/US7495099B2/en active Active
- 2003-10-29 JP JP2004548065A patent/JP4745664B2/ja not_active Expired - Fee Related
- 2003-10-29 WO PCT/JP2003/013838 patent/WO2004039869A1/ja active Application Filing
- 2003-10-29 RU RU2005116309/04A patent/RU2315782C2/ru active
- 2003-10-29 ES ES03769949.3T patent/ES2488841T3/es not_active Expired - Lifetime
- 2003-10-29 EP EP03769949.3A patent/EP1580216B1/en not_active Expired - Lifetime
- 2003-10-29 DK DK03769949.3T patent/DK1580216T3/da active
- 2003-10-29 AU AU2003280592A patent/AU2003280592B2/en not_active Ceased
- 2003-10-29 CN CNB2003801025487A patent/CN1309763C/zh not_active Expired - Fee Related
- 2003-10-29 KR KR1020057007500A patent/KR101057102B1/ko active IP Right Grant
- 2003-10-29 CA CA2502870A patent/CA2502870C/en not_active Expired - Fee Related
- 2003-10-29 PT PT37699493T patent/PT1580216E/pt unknown
- 2003-10-30 TW TW092130275A patent/TW200418906A/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1309763C (zh) | 2007-04-11 |
| WO2004039869A1 (ja) | 2004-05-13 |
| KR20050070103A (ko) | 2005-07-05 |
| EP1580216A4 (en) | 2008-10-29 |
| AU2003280592B2 (en) | 2008-12-18 |
| EP1580216B1 (en) | 2014-05-14 |
| US20060067910A1 (en) | 2006-03-30 |
| JP4745664B2 (ja) | 2011-08-10 |
| PT1580216E (pt) | 2014-07-31 |
| KR101057102B1 (ko) | 2011-08-16 |
| JPWO2004039869A1 (ja) | 2006-03-02 |
| CN1708540A (zh) | 2005-12-14 |
| ES2488841T3 (es) | 2014-08-29 |
| EP1580216A1 (en) | 2005-09-28 |
| TW200418906A (en) | 2004-10-01 |
| CA2502870A1 (en) | 2004-05-13 |
| RU2005116309A (ru) | 2006-02-27 |
| AU2003280592A1 (en) | 2004-05-25 |
| US7495099B2 (en) | 2009-02-24 |
| TWI305538B (da) | 2009-01-21 |
| RU2315782C2 (ru) | 2008-01-27 |
| CA2502870C (en) | 2011-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1580216T3 (da) | Derivater med høj molekylvægt af camptotheciner | |
| DK1678208T3 (da) | Fjernelse af aggregater med høj molekylvægt under anvendelse af hydroxyapatitchromatografi | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| ATE411996T1 (de) | Kondensierte azolpyrimidinderivate | |
| CY2017048I1 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
| DK1501508T3 (da) | Inhibitorer af histondeatylase | |
| DK1453512T3 (da) | Acetylenderivater med mGluR5 antagonistisk virkning | |
| NO20054143D0 (no) | Pyrimidinderivater for forhindringen av HIV-infeksjon | |
| LTPA2011012I1 (lt) | Laktamą turintys junginiai ir jų dariniai kaip xa faktoriaus inhibitoriai | |
| ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
| DK1551802T3 (da) | Indol-3-svovlderivater | |
| DK1474408T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
| DK1622880T3 (da) | Substituerede dihydroquinazoliner med antivirale egenskaber | |
| NO20054854D0 (no) | Femrings heterocykliske derivater | |
| DK1537096T3 (da) | Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf | |
| DK1487832T3 (da) | Krystallinsk mikronisat af tiotropiumbromid | |
| DK1487840T3 (da) | Krystallinsk polymorf form af irinotecan hydrochlorid | |
| DE602004027811D1 (de) | Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon | |
| ATE335729T1 (de) | 3h-chinazoline -4-on derivaten | |
| IS8109A (is) | Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| NO20034525L (no) | Fenylheterocyklyleterderivater med serotonin re- opptaksinhibitorer | |
| DK1960387T3 (da) | Isoquinolin- og benzo[h]isoquinolinderivater, fremstilling deraf og terapeutisk anvendelse deraf som antagonister af histamin H3-receptoren | |
| IS8235A (is) | 2-amínóbensóýl afleiður |